National News

MoU signed between Ministry of Ayush and Department of Biotechnology

MoU will facilitate Inter-Ministerial Cooperation for evidence based biotechnological interventions in Ayush sector

Posted On: 25 MAY 2022 8:19PM by PIB Delhi

A Memorandum of Understanding (MoU) was signed between Ministry of Ayush and Department of Biotechnology, Government of India for mutual collaboration to explore the possibility of cooperation, convergence and synergy to bring out the expertise under one platform towards evidence based biotechnological interventions in Ayush sector. Secretary, Ministry of Ayush Vaidya Rajesh Kotecha and Secretary, Department of Biotechnology Dr. Rajesh S Gokhale were present on this occasion along with other official of both the ministries.

Through this association it is expected that traditional healthcare and biotechnology together would enable tremendous possibilities to undertake innovative and path-breaking research, which can be used for the exploration of various fundamental principles of Ayush systems. There is a need of multi-pronged and technological ways for the exploration and application of this ancient scientific system of health care into the public health care domain.

Biotechnological R & D and Ayush Interventions will improve quality of life as well as life span (Vayahsthaapana Rasayana) and bring down the associated morbidity pertaining to chronic diseases such as diabetes, obesity, cardiovascular disease, osteoarthritis, cachexia, pain management and infectious diseases for example Tuberculosis.

On this occasion, Vaidya Rajesh Kotecha said that MoU between Ministry of Ayush and DBT is expected to pave way for coordinated researches in Ayush sector and the huge untapped potential of Ayush health care system may be utilized for the community benefit.

Addressing the gathering, Dr. Rajesh S Gokhale said that this Inter Ministerial cooperation between Ministry of Ayush and DBT is expected to generate knowledge and new means of intervention strategies for difficult to treat diseases.

This joint R&D effort ranging from fundamental science to validation and thereafter product development, will significantly help in the growth of the Indian contributions to this important sector, not only nationally but internationally as well. Emphasis would be given to mechanistic studies of Ayurveda Therapeutics using animal models of disease and other advanced analytical methods along with data analytical tools.

*****

SK

Also See:

newsonline

Recent Posts

Salesforce Brings The First Edition of Agentforce World Tour To Delhi

Salesforce, the worlds #1 CRM, powered by AI technology and capabilities, today hosted India's first…

13 hours ago

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2…

13 hours ago

Sachidanand Upadhyay: A Visionary Leader Dedicated to Building Better Tomorrow

At Lord's Mark Industries Limited, led by Sachidanand Upadhyay, we are committed to fostering positive…

13 hours ago

HDFC Life Launches ‘The Missing Beat – Second Chance’

After the success of the first phase of 'The Missing Beat', a campaign aimed at…

13 hours ago

Raghu Vamsi Aerospace Group Lays Foundation Stone to Build New Facility in Hyderabad with the Investment of Rs.300 Crore

Laid the foundation stone by Shri D. Sridhar Babu, Minister of IT, Electronics, Communications, Industries…

14 hours ago

Global Recognition for Chitkara University in Times Higher Education Interdisciplinary Science Rankings 2025

Chitkara University has earned a prominent place on the global academic stage, ranking 161st in…

14 hours ago